688075 安旭生物
午间休市 12-11 11:29:00
资讯
新帖
简况
每周股票复盘:安旭生物(688075)股东拟减持不超0.94%股份
证券之星 · 11-23
每周股票复盘:安旭生物(688075)股东拟减持不超0.94%股份
安旭生物(688075.SH)股东马华祥拟减持不超0.94%股份
智通财经 · 11-18
安旭生物(688075.SH)股东马华祥拟减持不超0.94%股份
安旭生物(688075)披露召开2025年第三季度业绩说明会,11月17日股价下跌2.72%
证券之星 · 11-17
安旭生物(688075)披露召开2025年第三季度业绩说明会,11月17日股价下跌2.72%
安旭生物(688075)9月30日股东户数0.61万户,较上期增加1.1%
证券之星 · 10-30
安旭生物(688075)9月30日股东户数0.61万户,较上期增加1.1%
安旭生物公布国际专利申请:“液体样品检测装置”
证券之星 · 10-18
安旭生物公布国际专利申请:“液体样品检测装置”
安旭生物新注册《安旭生物配置文件生成系统V1.0》等2个项目的软件著作权
证券之星 · 10-11
安旭生物新注册《安旭生物配置文件生成系统V1.0》等2个项目的软件著作权
安旭生物新注册《多工位粘膜机软件V1.0》项目的软件著作权
证券之星 · 09-18
安旭生物新注册《多工位粘膜机软件V1.0》项目的软件著作权
每周股票复盘:安旭生物(688075)将召开2025年半年度业绩说明会
证券之星 · 09-07
每周股票复盘:安旭生物(688075)将召开2025年半年度业绩说明会
安旭生物:9月22日将召开2025年半年度业绩说明会
证券日报网 · 09-03
安旭生物:9月22日将召开2025年半年度业绩说明会
医疗器械行业行业研究:脑机接口行业深度:政策+创新双轮驱动,商业化落地进入快车道
国金证券 · 08-10
医疗器械行业行业研究:脑机接口行业深度:政策+创新双轮驱动,商业化落地进入快车道
每周股票复盘:安旭生物(688075)董事会换届及资金管理议案待审议
证券之星 · 08-10
每周股票复盘:安旭生物(688075)董事会换届及资金管理议案待审议
安旭生物:8月6日召开董事会会议
每日经济新闻 · 08-06
安旭生物:8月6日召开董事会会议
安旭生物:拟使用不超40亿元的部分暂时闲置自有资金进行现金管理
格隆汇资讯 · 08-06
安旭生物:拟使用不超40亿元的部分暂时闲置自有资金进行现金管理
医药利好!中国在艾滋病疫苗研发领域取得重要进展
格隆汇 · 08-04
医药利好!中国在艾滋病疫苗研发领域取得重要进展
A股生物医药股拉升,天坛生物涨停
格隆汇 · 08-04
A股生物医药股拉升,天坛生物涨停
安旭生物新注册《安旭生物全自动污水处理系统V1.0》项目的软件著作权
证券之星 · 07-22
安旭生物新注册《安旭生物全自动污水处理系统V1.0》项目的软件著作权
安旭生物中标1.23万元 小单中标对公司业绩影响有限
自选股中标信息 · 07-18
安旭生物中标1.23万元 小单中标对公司业绩影响有限
多家跨国医疗巨头奔赴链博会,本土药械供应链再升级
第一财经 · 07-16
多家跨国医疗巨头奔赴链博会,本土药械供应链再升级
每周股票复盘:安旭生物(688075)每股派发现金红利0.8元
证券之星 · 07-13
每周股票复盘:安旭生物(688075)每股派发现金红利0.8元
安旭生物获得外观设计专利授权:“尿杯检测仪”
证券之星 · 07-12
安旭生物获得外观设计专利授权:“尿杯检测仪”
加载更多
公司概况
公司名称:
杭州安旭生物科技股份有限公司
所属行业:
医药制造业
上市日期:
2021-11-18
主营业务:
杭州安旭生物科技股份有限公司的主营业务是POCT试剂及仪器的研发、生产与销售。公司的主要产品是毒品检测试剂、传染病检测试剂、慢性病检测试剂、妊娠检测试剂、肿瘤检测试剂、心肌检测试剂、生化检测试剂、过敏原检测试剂。公司作为国家级专精特新“小巨人”企业、杭州市企业高新技术研究开发中心、国家高新技术企业、省级高新技术企业研究开发中心,荣获国家知识产权优势企业、浙江省高新技术企业创新能力百强等荣誉称号。
发行价格:
78.28
{"stockData":{"symbol":"688075","market":"SH","secType":"STK","nameCN":"安旭生物","latestPrice":38.55,"timestamp":1765423740000,"preClose":38.99,"halted":0,"volume":183222,"delay":0,"changeRate":-0.0113,"floatShares":127000000,"shares":127000000,"eps":0.9512,"marketStatus":"午间休市","change":-0.44,"latestTime":"12-11 11:29:00","open":38.88,"high":38.94,"low":38.5,"amount":7082800,"amplitude":0.0113,"askPrice":38.59,"askSize":2,"bidPrice":38.55,"bidSize":6,"shortable":0,"etf":0,"ttmEps":0.9512,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765429200000},"marketStatusCode":3,"adr":0,"adjPreClose":38.99,"symbolType":"stock_kcb","openAndCloseTimeList":[[1765416600000,1765423800000],[1765429200000,1765436400000]],"highLimit":42.89,"lowLimit":35.09,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":127082805,"isCdr":false,"pbRate":0.96,"roa":"--","peRate":40.527754,"roe":"1.23%","epsLYR":1.51,"committee":0.333333,"marketValue":4899000000,"turnoverRate":0.0014,"status":1,"floatMarketCap":4899000000},"requestUrl":"/m/hq/s/688075","defaultTab":"news","newsList":[{"id":"2585105549","title":"每周股票复盘:安旭生物(688075)股东拟减持不超0.94%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2585105549","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585105549?lang=zh_cn&edition=full","pubTime":"2025-11-23 03:31","pubTimestamp":1763839873,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘,安旭生物报收于38.85元,较上周的43.33元下跌10.34%。本周关注点股本股东变化:股东马华祥计划减持不超过公司总股本的0.94%。安旭生物股东减持股份计划公告杭州安旭生物科技股份有限公司股东马华祥持有公司股份14,773,360股,占总股本的11.62%,股份来源于首次公开发行前取得。因自身资金需求,马华祥计划通过集中竞价交易方式减持不超过1,200,000股,即不超过公司总股本的0.94%。本次减持计划与此前承诺一致,不存在导致公司控制权变更的风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300000901.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"gpt_icon":0},{"id":"2584931860","title":"安旭生物(688075.SH)股东马华祥拟减持不超0.94%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2584931860","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584931860?lang=zh_cn&edition=full","pubTime":"2025-11-18 19:24","pubTimestamp":1763465086,"startTime":"0","endTime":"0","summary":"智通财经APP讯,安旭生物(688075.SH)发布公告,股东马华祥因自身资金需求,拟通过集中竞价交易方式减持其所持有的公司股份数量合计不超过120万股,即不超过公司总股本的0.94%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1370660.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688075"],"gpt_icon":0},{"id":"2584253621","title":"安旭生物(688075)披露召开2025年第三季度业绩说明会,11月17日股价下跌2.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584253621","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584253621?lang=zh_cn&edition=full","pubTime":"2025-11-17 22:22","pubTimestamp":1763389321,"startTime":"0","endTime":"0","summary":"截至2025年11月17日收盘,安旭生物报收于42.15元,较前一交易日下跌2.72%,最新总市值为53.57亿元。该股当日开盘43.33元,最高43.33元,最低41.85元,成交额达5499.81万元,换手率为1.02%。公司近日发布公告称,杭州安旭生物科技股份有限公司将于2025年11月25日14:00-15:00通过上证路演中心网络互动方式召开2025年第三季度业绩说明会,介绍公司2025年第三季度经营成果、财务状况,并回答投资者提问。投资者可于11月18日至11月24日16:00前通过上证路演中心或公司邮箱提交问题。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111700037036.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"gpt_icon":0},{"id":"2579684118","title":"安旭生物(688075)9月30日股东户数0.61万户,较上期增加1.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579684118","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579684118?lang=zh_cn&edition=full","pubTime":"2025-10-30 17:27","pubTimestamp":1761816453,"startTime":"0","endTime":"0","summary":"证券之星消息,近日安旭生物披露,截至2025年9月30日公司股东户数为6090.0户,较6月30日增加66.0户,增幅为1.1%。在医疗器械行业个股中,安旭生物股东户数低于行业平均水平,截至9月30日,医疗器械行业平均股东户数为2.21万户。从股价来看,2025年6月30日至2025年9月30日,安旭生物区间涨幅为3.43%,在此期间股东户数增加66.0户,增幅为1.1%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000033073.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"gpt_icon":0},{"id":"2576606407","title":"安旭生物公布国际专利申请:“液体样品检测装置”","url":"https://stock-news.laohu8.com/highlight/detail?id=2576606407","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576606407?lang=zh_cn&edition=full","pubTime":"2025-10-18 05:19","pubTimestamp":1760735981,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示安旭生物(688075)公布了一项国际专利申请,专利名为“液体样品检测装置”,专利申请号为PCT/CN2025/099691,国际公布日为2025年10月16日。专利详情如下:图片来源:世界知识产权组织(WIPO)今年以来安旭生物已公布的国际专利申请1个。结合公司2025年中报财务数据,今年上半年公司在研发方面投入了4741万元,同比减4.56%。数据来源:企查查以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101800003786.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"gpt_icon":0},{"id":"2574109293","title":"安旭生物新注册《安旭生物配置文件生成系统V1.0》等2个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2574109293","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574109293?lang=zh_cn&edition=full","pubTime":"2025-10-11 02:00","pubTimestamp":1760119252,"startTime":"0","endTime":"0","summary":"证券之星消息,近日安旭生物新注册了2个项目的软件著作权,包括《安旭生物配置文件生成系统V1.0》、《安旭生物凝血分析仪软件V1.0》等。今年以来安旭生物新注册软件著作权13个,较去年同期增加了333.33%。通过天眼查大数据分析,杭州安旭生物科技股份有限公司共对外投资了18家企业,参与招投标项目137次;财产线索方面有商标信息76条,专利信息230条,著作权信息54条;此外企业还拥有行政许可104个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101100000936.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"gpt_icon":0},{"id":"2568421415","title":"安旭生物新注册《多工位粘膜机软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2568421415","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568421415?lang=zh_cn&edition=full","pubTime":"2025-09-18 01:50","pubTimestamp":1758131430,"startTime":"0","endTime":"0","summary":"证券之星消息,近日安旭生物新注册了《多工位粘膜机软件V1.0》项目的软件著作权。今年以来安旭生物新注册软件著作权11个,较去年同期增加了266.67%。结合公司2025年中报财务数据,今年上半年公司在研发方面投入了4741万元,同比减4.56%。通过天眼查大数据分析,杭州安旭生物科技股份有限公司共对外投资了18家企业,参与招投标项目133次;财产线索方面有商标信息76条,专利信息230条,著作权信息53条;此外企业还拥有行政许可104个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091800001061.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"gpt_icon":0},{"id":"2565545429","title":"每周股票复盘:安旭生物(688075)将召开2025年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2565545429","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565545429?lang=zh_cn&edition=full","pubTime":"2025-09-07 06:45","pubTimestamp":1757198715,"startTime":"0","endTime":"0","summary":"截至2025年9月5日收盘,安旭生物报收于39.56元,较上周的40.22元下跌1.64%。本周,安旭生物9月1日盘中最高价报40.55元。本周关注点公司公告汇总:安旭生物将于2025年9月22日召开2025年半年度业绩说明会,投资者可提前提交问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090700001421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"gpt_icon":0},{"id":"2564667398","title":"安旭生物:9月22日将召开2025年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2564667398","media":"证券日报网","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564667398?lang=zh_cn&edition=full","pubTime":"2025-09-03 18:39","pubTimestamp":1756895940,"startTime":"0","endTime":"0","summary":"证券日报网讯9月3日晚间,安旭生物发布公告称,公司计划于2025年9月22日(星期一)14:00-15:00举行2025年半年度业绩说明会。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-03/doc-infpfnya7673889.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-03/doc-infpfnya7673889.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688075","BK0239"],"gpt_icon":0},{"id":"2558835566","title":"医疗器械行业行业研究:脑机接口行业深度:政策+创新双轮驱动,商业化落地进入快车道","url":"https://stock-news.laohu8.com/highlight/detail?id=2558835566","media":"国金证券","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558835566?lang=zh_cn&edition=full","pubTime":"2025-08-10 12:06","pubTimestamp":1754798792,"startTime":"0","endTime":"0","summary":"投资逻辑国内政策叠加资本双重支持,行业迎来重大发展机遇。近年来国内政策端对脑机接口行业支持力度较高,支持性政策在产品注册、医保支付、行业标准等层面均有体现。1)在产品注册方面,国家药监局将配合相关部门出台基于脑机接口技术的医疗器械产品支持政策,脑机接口相关产品有望通过创新器械绿色通道实现更快注册审批。其中医疗健康领域仍是脑机接口应用最大的细分领域。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081012063594da7295&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081012063594da7295&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688050","688468","688580","688426","688085","688298","688075","688613","688273","603014","688366","688607","688289","688193","688212","603387","688161","688351","688575","603880","688677","603987","603976","600587","688253","688581","688013","688606","560260","603205","688029","688301","688016","605369","688358","688617","688139","159883","600055","688393","603658","688576","688314","688217","688108","603309","688198","688410","688026","688656","603222","688271","688067","688151","688755","688338","688317","600807","688114","688767","600645","688277","688236","688389","600529","688068"],"gpt_icon":0},{"id":"2558008805","title":"每周股票复盘:安旭生物(688075)董事会换届及资金管理议案待审议","url":"https://stock-news.laohu8.com/highlight/detail?id=2558008805","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558008805?lang=zh_cn&edition=full","pubTime":"2025-08-10 04:00","pubTimestamp":1754769641,"startTime":"0","endTime":"0","summary":"截至2025年8月8日收盘,安旭生物报收于42.04元,较上周的41.6元上涨1.06%。本周,安旭生物8月5日盘中最高价报44.13元。本周关注点公司公告汇总:安旭生物董事会换届选举议案及取消监事会等议案需提交股东大会审议。公司公告汇总:安旭生物拟使用不超过40亿元暂时闲置自有资金进行现金管理。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081000000762.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"gpt_icon":0},{"id":"2557203763","title":"安旭生物:8月6日召开董事会会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2557203763","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557203763?lang=zh_cn&edition=full","pubTime":"2025-08-06 17:55","pubTimestamp":1754474103,"startTime":"0","endTime":"0","summary":"每经AI快讯,安旭生物(SH 688075,收盘价:42.29元)8月6日晚间发布公告称,公司第二届第十八次董事会会议于2025年8月6日以现场结合通讯表决方式召开。会议审议了《关于董事会换届选举暨提名第三届董事会非独立董事候选人的议案》等文件。2024年1至12月份,安旭生物的营业收入构成为:体外诊断行业占比100.0%。截至发稿,安旭生物市值为54亿元。每经头条(nbdtoutiao)——国企员工3.6亿元接手徐翔母亲股份!知情人:李蓉蓉非宁波海关下属企业中干,亲戚募的钱,推她为牵头人(记者 曾健辉)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806175725973733fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806175725973733fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688075"],"gpt_icon":0},{"id":"2557371288","title":"安旭生物:拟使用不超40亿元的部分暂时闲置自有资金进行现金管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2557371288","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557371288?lang=zh_cn&edition=full","pubTime":"2025-08-06 17:29","pubTimestamp":1754472554,"startTime":"0","endTime":"0","summary":"格隆汇8月6日丨安旭生物(688075.SH)公布,公司拟使用不超过人民币40亿元的部分暂时闲置自有资金,通过银行、证券公司等具有合法经营资格的金融机构购买安全性高、流动性好、有保本约定的投资理财产品(包括但不限于购买保本型理财产品、结构性存款、大额存单、定期存款等),使用期限为2025年9月18日起12个月内有效。在上述额度及期限内,资金可以滚动使用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080617292994d31e72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080617292994d31e72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688075","BK0239"],"gpt_icon":0},{"id":"2556803540","title":"医药利好!中国在艾滋病疫苗研发领域取得重要进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2556803540","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556803540?lang=zh_cn&edition=full","pubTime":"2025-08-04 14:17","pubTimestamp":1754288268,"startTime":"0","endTime":"0","summary":"中国疾控中心艾防中心等团队完成我国首个复制型天坛痘苗载体艾滋病疫苗I期临床试验。该研究创新性采用曾用于消灭天花的“天坛株”痘苗病毒为载体,试验验证了该方案的安全性且能激发有效免疫反应。这标志着我国在艾滋病疫苗研发领域取得重要进展。受此影响,A股市场生物医药股拉升,其中,南模生物、赛伦生物涨超14%,天坛生物10CM涨停,之江生物、沃森生物、仁度生物、安旭生物等跟涨。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508041417529732155c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508041417529732155c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688317","688193","BK0239","159938","159646","688075"],"gpt_icon":0},{"id":"2556808919","title":"A股生物医药股拉升,天坛生物涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2556808919","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556808919?lang=zh_cn&edition=full","pubTime":"2025-08-04 14:05","pubTimestamp":1754287523,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1141","BK0185","688317","03347","BK0046","BK1583","BK0070","BK0239","688193","159982","688265","BK0010","688163","300142","BK0216","161726","BK0028","600161","399441","BK0082","BK0168","BK0188","159646","688075","BK1576","399300","BK0077"],"gpt_icon":0},{"id":"2553406894","title":"安旭生物新注册《安旭生物全自动污水处理系统V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2553406894","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553406894?lang=zh_cn&edition=full","pubTime":"2025-07-22 01:46","pubTimestamp":1753119974,"startTime":"0","endTime":"0","summary":"证券之星消息,近日安旭生物新注册了《安旭生物全自动污水处理系统V1.0》项目的软件著作权。今年以来安旭生物新注册软件著作权10个,较去年同期增加了233.33%。结合公司2024年年报财务数据,2024年公司在研发方面投入了1.01亿元,同比减3.99%。通过天眼查大数据分析,杭州安旭生物科技股份有限公司共对外投资了18家企业,参与招投标项目129次;财产线索方面有商标信息76条,专利信息216条,著作权信息52条;此外企业还拥有行政许可97个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072200001101.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"gpt_icon":0},{"id":"2552624964","title":"安旭生物中标1.23万元 小单中标对公司业绩影响有限","url":"https://stock-news.laohu8.com/highlight/detail?id=2552624964","media":"自选股中标信息","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552624964?lang=zh_cn&edition=full","pubTime":"2025-07-18 18:44","pubTimestamp":1752835464,"startTime":"0","endTime":"0","summary":"2025年07月18日,据天眼查数据,毒检试剂竞价成交公告显示,中标方为安旭生物(sh688075),招标方为湖南省株洲监狱,金额1.23万元。安旭生物主营业务涵盖快速诊断试剂(占比约100.00%)。截至发稿,安旭生物股价报40.44元,上涨0.67%,成交额至3769.32万元(5日均值6632.44万元)。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。中标数据由天眼查提供,由程序或算法识别中标信息页面生成,可能与实际存在差异,不作为决策依据。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718184433a45355bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718184433a45355bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688075"],"gpt_icon":0},{"id":"2551662190","title":"多家跨国医疗巨头奔赴链博会,本土药械供应链再升级","url":"https://stock-news.laohu8.com/highlight/detail?id=2551662190","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551662190?lang=zh_cn&edition=full","pubTime":"2025-07-16 00:15","pubTimestamp":1752596100,"startTime":"0","endTime":"0","summary":"第一财经记者获悉,即将于7月16日开幕的第三届中国国际供应链促进博览会,包括美敦力、阿斯利康、GE医疗等跨国医疗巨头确认参展。美敦力方面介绍,今年是该公司首次参加链博会,并将展示一款全新的由美敦力中国研发中心和本土临床专家合作的起搏心脏导管研发成果。在本届链博会上,阿斯利康国际市场供应链管理高级执行总裁Steven Rota也将发表主旨演讲。阿斯利康已连续第三年参加链博会。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716062402a44d2312&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716062402a44d2312&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688151","688606","600529","688351","688393","688576","688656","600587","688617","688273","688317","688767","603387","603301","688271","688575","603222","603880","688108","688085","688198","688139","688016","688358","688399","603987","688161","688607","688613","600645","603014","603658","688253","688580","688050","688067","688193","688212","688298","688389","BK0239","688026","688068","603309","688236","688626","688468","159891","688029","600807","688301","688426","688410","688755","688338","688075","600055","603976","688114","688289","688581","688217","688677","603205","688013","605369","688314","688366"],"gpt_icon":0},{"id":"2551914879","title":"每周股票复盘:安旭生物(688075)每股派发现金红利0.8元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551914879","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551914879?lang=zh_cn&edition=full","pubTime":"2025-07-13 06:16","pubTimestamp":1752358572,"startTime":"0","endTime":"0","summary":"截至2025年7月11日收盘,安旭生物报收于39.01元,较上周的38.85元上涨0.41%。本周,安旭生物7月8日盘中最高价报39.59元。本周关注点公司公告汇总:安旭生物每股派发现金红利0.8元,股权登记日为2025年7月17日公司公告汇总安旭生物2024年年度权益分派实施公告指出,每股将分配现金红利0.8元,相关日期包括股权登记日2025年7月17日,除权(息)日及现金红利发放日均为2025年7月18日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071300001135.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"gpt_icon":0},{"id":"2550659759","title":"安旭生物获得外观设计专利授权:“尿杯检测仪”","url":"https://stock-news.laohu8.com/highlight/detail?id=2550659759","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550659759?lang=zh_cn&edition=full","pubTime":"2025-07-12 02:38","pubTimestamp":1752259095,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示安旭生物新获得一项外观设计专利授权,专利名为“尿杯检测仪”,专利申请号为CN202430628551.7,授权日为2025年6月27日。今年以来安旭生物新获得专利授权29个,较去年同期增加了262.5%。通过天眼查大数据分析,杭州安旭生物科技股份有限公司共对外投资了18家企业,参与招投标项目126次;财产线索方面有商标信息76条,专利信息216条,著作权信息52条;此外企业还拥有行政许可91个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071200001161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765427096247,"stockEarnings":[{"period":"1week","weight":-0.0104},{"period":"1month","weight":-0.0432},{"period":"3month","weight":-0.0196},{"period":"6month","weight":0.0509},{"period":"1year","weight":-0.0036},{"period":"ytd","weight":0.0783}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":-0.0294},{"period":"3month","weight":0.0065},{"period":"6month","weight":0.155},{"period":"1year","weight":0.1396},{"period":"ytd","weight":0.1637}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"杭州安旭生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"6090人(较上一季度增加1.10%)","perCapita":"20867股","listingDate":"2021-11-18","address":"浙江省杭州市余杭区莫干山路1418-50号4幢3层(上城科技工业基地)","registeredCapital":"12708万元","survey":" 杭州安旭生物科技股份有限公司的主营业务是POCT试剂及仪器的研发、生产与销售。公司的主要产品是毒品检测试剂、传染病检测试剂、慢性病检测试剂、妊娠检测试剂、肿瘤检测试剂、心肌检测试剂、生化检测试剂、过敏原检测试剂。公司作为国家级专精特新“小巨人”企业、杭州市企业高新技术研究开发中心、国家高新技术企业、省级高新技术企业研究开发中心,荣获国家知识产权优势企业、浙江省高新技术企业创新能力百强等荣誉称号。","listedPrice":78.28},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"安旭生物(688075)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供安旭生物(688075)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"安旭生物,688075,安旭生物股票,安旭生物股票老虎,安旭生物股票老虎国际,安旭生物行情,安旭生物股票行情,安旭生物股价,安旭生物股市,安旭生物股票价格,安旭生物股票交易,安旭生物股票购买,安旭生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"安旭生物(688075)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供安旭生物(688075)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}